Population pharmacokinetics of nevirapine, zidovudine and didanosine after combination therapy in HIV-infected patients.

被引：0
|
作者：
Zhou, XJ
Sheiner, LB
D'Aquila, RT
Hughes, MD
Hirsch, MS
Fischl, MA
Johnson, VA
Myers, M
Sommadossi, JP
机构：
[1] Univ Alabama, Sch Med, Vet Affairs Med Ctr, Dept Pharmacol,Div Clin Pharmacol & Infect Dis, Birmingham, AL USA
[2] Univ Alabama, Sch Med, Vet Affairs Med Ctr, Dept Med,Div Clin Pharmacol & Infect Dis, Birmingham, AL USA
[3] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA
[4] Univ Calif San Francisco, Dept Biopharmaceut Sci & Med, San Francisco, CA 94143 USA
[5] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Infect Dis Unit, Boston, MA USA
[6] Harvard Univ, Massachusetts Gen Hosp, Sch Med, AIDS Res Ctr, Boston, MA USA
[7] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA
[8] London Sch Hyg & Trop Med, London WC1, England
[9] Univ Miami, Sch Med, Miami, FL USA
[10] Boehringer Ingelheim Pharmaceut Inc, Ridgefield, CT 06877 USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 1998年 / 63卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
PII39
引用
收藏
页码：182 / 182
页数：1
相关论文
共 50 条
  • [1] Quality of life outcomes of combination zidovudine-didanosine-nevirapine and zidovudine-didanosine for antiretroviral-naive advanced HIV-infected patients
    Bucciardini, R
    Wu, AW
    Floridia, M
    Fragola, V
    Ricciardulli, D
    Tomino, C
    Weimer, LE
    Pirillo, MF
    Mirra, M
    Marzi, M
    Giannini, G
    Galluzzo, CM
    Andreotti, M
    Massella, M
    Vella, S
    [J]. AIDS, 2000, 14 (16) : 2567 - 2574
  • [2] Population pharmacokinetics of nevirapine, zidovudine, and didanosine in human immunodeficiency virus-infected patients
    Zhou, XJ
    Sheiner, LB
    D'Aquila, RT
    Hughes, MD
    Hirsch, MS
    Fischl, MA
    Johnson, VA
    Myers, M
    Sommadossi, JP
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (01) : 121 - 128
  • [3] Population pharmacokinetics of nevirapine in Thai HIV-infected patients
    Wattanakul, Thanaporn
    Avihingsanon, Anchalee
    Manosuthi, Weerawat
    Punyawudho, Baralee
    [J]. ANTIVIRAL THERAPY, 2014, 19 (07) : 651 - 660
  • [4] Pharmacokinetics of oral ganciclovir alone and in combination with zidovudine, didanosine, and probenecid in HIV-infected subjects
    Cimoch, PJ
    Lavelle, J
    Pollard, R
    Griffy, KG
    Wong, R
    Tarnowski, TL
    Casserella, S
    Jung, D
    [J]. JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1998, 17 (03): : 227 - 234
  • [5] TOLERANCE OF A TRIPLE COMBINATION THERAPY WITH ZIDOVUDINE, DIDANOSINE AND INTERFERON-ALPHA IN 7 HIV-INFECTED PATIENTS
    BISSUEL, F
    TRABAUD, MA
    LERICHE, K
    COTTE, L
    SCHLIENGER, I
    ROUGIER, P
    TREPO, C
    [J]. AIDS, 1995, 9 (11) : 1285 - 1285
  • [6] DIDANOSINE RESISTANCE IN HIV-INFECTED PATIENTS SWITCHED FROM ZIDOVUDINE TO DIDANOSINE MONOTHERAPY
    KOZAL, MJ
    KROODSMA, K
    WINTERS, MA
    SHAFER, RW
    EFRON, B
    KATZENSTEIN, DA
    MERIGAN, TC
    [J]. ANNALS OF INTERNAL MEDICINE, 1994, 121 (04) : 263 - 268
  • [7] PHARMACOKINETICS OF PHOSPHORYLATED ZIDOVUDINE IN HIV-INFECTED PATIENTS
    STRETCHER, BN
    PESCE, AJ
    HURTUBISE, PE
    FRAME, PT
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1992, 51 (02) : 182 - 182
  • [8] Nevirapine, didanosine, and zidovudine for patients with HIV: The INCAS trial
    Haubrich, R
    Richman, D
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 281 (02): : 130 - 131
  • [9] PHARMACOKINETICS OF ZIDOVUDINE AND DIDANOSINE DURING COMBINATION THERAPY
    MORSE, GD
    SHELTON, MJ
    HO, M
    BARTOS, L
    DEREMER, M
    RAGNI, M
    [J]. ANTIVIRAL RESEARCH, 1995, 27 (04) : 419 - 424
  • [10] IN HIV-INFECTED INDIVIDUALS WHO DESIRE COMBINATION ANTIVIRAL THERAPY, ZIDOVUDINE PLUS ZALCITABINE IS PREFERRED TO ZIDOVUDINE PLUS DIDANOSINE
    CARR, A
    COOPER, DA
    [J]. REVIEWS IN MEDICAL VIROLOGY, 1994, 4 (01) : 5 - 8
12345